Magnetic resonance spectroscopy and imaging of the thalamus in idiopathic generalized epilepsy

Brain

Volumn 126, Issue 11, 2003, Pages 2447-2454

  Bernasconi, Andrea ^a   Bernasconi, N ^a   Natsume, J ^a   Antel, S B ^a   Andermann, F ^a   Arnold, D L ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

Idiopathic generalized epilepsy; MRI; Proton magnetic resonance spectroscopic imaging; Thalamus

Indexed keywords

CHOLINE; CREATININE; N ACETYLASPARTIC ACID;

ADULT; ARTICLE; BRAIN METABOLISM; BRAIN SIZE; CLINICAL ARTICLE; CONTROLLED STUDY; ELECTROENCEPHALOGRAPHY; EPILEPSY; FEMALE; HUMAN; IDIOPATHIC DISEASE; IMAGING SYSTEM; MALE; NEURORADIOLOGY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; THALAMUS;

ADULT; ASPARTIC ACID; CHOLINE; CREATINE; ELECTROENCEPHALOGRAPHY; EPILEPSY, GENERALIZED; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; THALAMUS; TIME FACTORS;

EID: 0142184242     PISSN: 00068950     EISSN: None     Source Type: Journal    
DOI: 10.1093/brain/awg249     Document Type: Article

References (55)

1. Andermann F, Berkovic SF. Idiopathic generalized epilepsy with generalized and other seizures in adolescence. Epilepsia 2001; 42: 317-20.
2. Avanzini G, de Curtis M, Franceschetti S, Sancini G, Spreafico R. Cortical versus thalamic mechanisms underlying spike and wave discharges in GAERS. Epilepsy Res 1996; 26: 37-44.
3. Avoli M, Rogawski MA, Avanzini G. Generalized epileptic disorders: an update. Epilepsia 2001; 42: 445-57.
4. Bernasconi A, Cendes F, Shoubridge EA, Andermann E, Li LM, Arnold DL, et al. Spectroscopic imaging of frontal neuronal dysfunction in hyperekplexia. Brain 1998; 121: 1507-12.
5. Bernasconi A, Tasch E, Cendes F, Li LM, Arnold DL. Proton magnetic resonance spectroscopic imaging suggests progressive neuronal damage in human temporal lobe epilepsy. Prog Brain Res 2002; 135: 297-304.
6. Bertolino A, Nawroz S, Mattay VS, Barnett AS, Duyn JH, Moonen CT, et al. Regionally specific pattern of neurochemical pathology in schizophrenia as assessed by multislice proton magnetic resonance spectroscopic imaging. Am J Psychiatry 1996; 153: 1554-63.
7. Bertolino A, Callicott JH, Elman I, Mattay VS, Tedeschi G, Frank JA, et al. Regionally specific neuronal pathology in untreated patients with schizophrenia: a proton magnetic resonance spectroscopic imaging study. Biol Psychiatry 1998; 43: 641-8.
8. Bjartmar C, Battistuta J, Terada N, Dupree E, Trapp BD. N-acetylaspartate is an axon-specific marker of mature white matter in vivo: a biochemical and immunohistochemical study on the rat optic nerve. Ann Neurol 2002; 51: 51-8.
9. Cendes F, Andermann F, Dubeau F, Matthews PM, Arnold DL. Normalization of neuronal metabolic dysfunction after surgery for temporal lobe epilepsy. Evidence from proton MR spectroscopic imaging. Neurology 1997a; 49: 1525-33.
10. Cendes F, Caramanos Z, Andermann F, Dubeau F, Arnold DL. Proton magnetic resonance spectroscopic imaging and magnetic resonance imaging volumetry in the lateralization of temporal lobe epilepsy: a series of 100 patients. Ann Neurol 1997b; 42: 737-46.
11. Collins DL, Neelin P, Peters TM, Evans AC. Automatic 3D intersubject registration of MR volumetric data in standardized Talairach space. J Comput Assist Tomogr 1994; 18: 192-205.
12. Commission on Classification and Terminology of the International League Against Epilepsy. Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia 1989; 30: 389-99.
13. Connelly A, Van Paesschen W, Porter DA, Johnson CL, Duncan JS, Gadian DG. Proton magnetic resonance spectroscopy in MRI-negative temporal lobe epilepsy. Neurology 1998; 51: 61-6.
14. Cox CL, Huguenard JR, Prince DA. Nucleus reticularis neurons mediate diverse inhibitory effects in thalamus. Proc Natl Acad Sci USA 1997; 94: 8854-9.
15. Danober L, Deransart C, Depaulis A, Vergnes M, Marescaux C. Pathophysiological mechanisms of genetic absence epilepsy in the rat. Prog Neurobiol 1998; 55: 27-57.
16. Dautry C, Vaufrey F, Brouillet E, Bizat N, Henry PG, Conde F, et al. Early N-acetylaspartate depletion is a marker of neuronal dysfunction in rats and primates chronically treated with the mitochondrial toxin 3-nitropropionic acid. J Cereb Blood Flow Metab 2000; 20: 789-99.
17. de Beer R, van den Boogaart A, van Ormondt D, Pijnappel WW, den Hollander JA, Marien AJ, et al. Application of time-domain fitting in the quantification of in vivo 1H spectroscopic imaging data sets. NMR Biomed 1992; 5: 171-8.
18. DeStefano N, Matthews PM, Arnold DL. Reversible decreases in N-acetylaspartate after acute brain injury. Magn Reson Med 1995; 34: 721-7.
19. Demougeot C, Garnier P, Mossiat C, Bertrand N, Giroud M, Beley A, et al. N-Acetylaspartate, a marker of both cellular dysfunction and neuronal loss: its relevance to studies of acute brain injury. J Neurochem 2001; 77: 408-15.
20. Duncan JS. Idiopathic generalized epilepsies with typical absences. J Neurol 1997; 244: 403-11.
21. Fu L, Matthews PM, De Stefano N, Worsley KJ, Harayanan S, Francis GS, et al. Imaging axonal damage of normal-appearing white matter in multiple sclerosis. Brain 1998; 121: 103-13.
22. Gelisse P, Genton P, Thomas P, Rey M, Samuelian JC, Dravet C. Clinical factors of drug resistance in juvenile myoclonic epilepsy. J Neurol Neurosurg Psychiatry 2001; 70: 240-3.
23. Genton P, Gelisse P. Juvenile myoclonic epilepsy. Arch Neurol 2001; 58: 1487-90.
24. Gloor P. Generalized epilepsy with spike-and-wave discharge: a reinterpretation of its electrographic and clinical manifestations. The 1977 William G. Lennox Lecture, American Epilepsy Society. Epilepsia 1979; 20: 571-88.
25. Haase A, Frahm J, Hanicke W, Matthaei D. 1H NMR chemical shift selective (CHESS) imaging. Phys Med Biol 1985; 30: 341-4.
26. Hazlett EA, Buchsbaum MS, Byne W, Wei TC, Spiegel-Cohen J, Geneve C, et al. Three-dimensional analysis with MRI and PET of the size, shape, and function of the thalamus in the schizophrenia spectrum. Am J Psychiatry 1999; 156: 1190-9.
27. Hugg JW, Kuzniecky RI, Gilliam F, Morawetz RB, Faught E, Hetherington HP. Normalization of contralateral metabolic function following temporal lobectomy demonstrated by 1H magnetic resonance spectroscopic imaging. Ann Neurol 1996; 40: 236-9.
28. Huntsman MM, Porcello DM, Homanics GE, DeLorey TM, Huguenard JR. Reciprocal inhibitory connections and network synchrony in the mammalian thalamus. Science 1999; 283: 541-3.
29. Kalra S, Cashman NR, Genge A, Arnold DL. Recovery of N-acetylaspartate in corticomotor neurons of patients with ALS after riluzole therapy. Neuroreport 1998; 9: 1757-61.
30. Kretschmann HJ, Weinrich W. Cranial neuroimaging and clinical neuroanatomy: computed tomography and magnetic resonance imaging. 2nd ed. Stuttgart: Thieme Medical; 1992.
31. Li LM, Dubeau F, Andermann F, Arnold DL. Proton magnetic resonance spectroscopic imaging studies in patients with newly diagnosed partial epilepsy. Epilepsia 2000; 41: 825-31.
32. Matthews PM, Andermann F, Arnold DL. A proton magnetic resonance spectroscopy study of focal epilepsy in humans. Neurology 1990; 40: 985-9.
33. Meencke HJ, Janz D. Neuropathological findings in primary generalized epilepsy: a study of eight cases. Epilepsia 1984; 25: 8-21.
34. Meencke HJ, Janz D, Cervos-Navarro J. Neuropathology of primary generalized epilepsies with awakening grand mal. Acta Neuropathol. Suppl (Berl) 1981; 7: 378-80.
35. Miller SP, Li LM, Cendes F, Caramanos Z, Rosenblatt B, Shevell MI, et al. Neuronal dysfunction in children with newly diagnosed temporal lobe epilepsy. Pediatr Neurol 2000; 22: 281-6.
36. Moffett JR, Namboodiri MA, Cangro CB, Neale JH. Immunohistochemical localization of N-acetylaspartate in rat brain. Neuroreport 1991; 2: 131-4.
37. Mouritzen-Dam A, Moller A, Scheel-Kruger J, Jensen LH, Marescaux C, Vergnes M. Total number of neurons in the ventrolateral/posterior thalamic nuclei in a genetic petit mal-like rat strain. Epilepsy Res Suppl 1996; 12: 303-7.
38. Nakano M, Ueda H, Li JY, Matsumoto M, Yanagihara T. Measurement of regional N-acetylaspartate after transient global ischemia in gerbils with and without ischemic tolerance: an index of neuronal survival. Ann Neurol 1998; 44: 334-40.
39. Ordidge RJ, Mansfield P, Lohman JA, Prime SB. Volume selection using gradients and selective pulses. Ann NY Acad Sci 1987; 508: 376-85.
40. Petroff OA, Pleban LA, Spencer DD. Symbiosis between in vivo and in vitro NMR spectroscopy: the creatine, N-acetylaspartate, glutamate, and GABA content of the epileptic human brain. Magn Reson Imaging 1995; 13: 1197-11.
41. Petroff OA, Errante LD, Rothman DL, Kim JH, Spencer DD. Neuronal and glial metabolite content of the epileptogenic human hippocampus. Ann Neurol 2002; 52: 635-42.
42. Podell M, Hadjiconstantinou M. Cerebrospinal fluid gamma-aminobutyric acid and glutamate values in dogs with epilepsy. Am J Vet Res 1997; 58: 451-6.
43. 15O and PET. Neurology 1995; 45: 1396-1402.
44. Sabers A, Moller A, Scheel-Kruger J, Mouritzen Dam A. No loss in total neuron number in the thalamic reticular nucleus and neocortex in the genetic absence epilepsy rats from Strasbourg. Epilepsy Res 1996; 26: 45-8.
45. Savic I, Lekvall A, Greitz D, Helms G. MR spectroscopy shows reduced frontal lobe concentrations of N-acetyl aspartate in patients with juvenile myoclonic epilepsy. Epilepsia 2000; 41: 290-6.
46. Schaltenbrand G, Wahren W. Atlas for stereotaxy of the human brain. 2nd ed. Stuttgart: Thieme; 1977.
47. Simister RJ, McLean MA, Barker GJ, Duncan JS. A comparison of metabolite concentrations in primary generalized epilepsy and partial epilepsy using short echo time 1H spectrocopy and a double quantum GABA filter. In: Proceedings of the 10th International Conference of the International Society for Magnetic Resonance in Medicine; 2002 18-24 May; Honolulu, (HI), USA. Berkeley (CA), USA: International Society for Magnetic Resonance in Medicine; 2002. p. 420.
48. Simmons ML, Frondoza CG, Coyle JT. Immunocytochemical localization of N-acetyl-aspartate with monoclonal antibodies. Neuroscience 1991; 45: 37-45.
49. Sled JG, Zijdenbos AP, Evans AC. A nonparametric method for automatic correction of intensity nonuniformity in MRI data. IEEE Trans med Imaging 1998; 17: 87-97.
50. Steriade M, McCormick DA, Sejnowski TJ. Thalamocortical oscillations in the sleeping and aroused brain. [Review]. Science 1993; 262: 679-85.
51. Talairach J, Tournoux P. Co-planar stereotaxic atlas of the human brain. Stuttgart: Thieme Medical; 1988.
52. Tsai G, Coyle JT. N-acetylaspartate in neuropsychiatric disorders. Prog Neurobiol 1995; 46: 531-40.
53. Tsai G, Passani LA, Slusher BS, Carter R, Baer L, Kleionman JE, et al. Abnormal excitatory neurotransmitter metabolism in schizophrenic brains. Arch Gen Psychiatry 1995; 52: 829-36.
54. Urenjak J, Williams SR, Gadian DG, Noble M. Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types. J Neurosci 1993; 13: 981-9.
55. Vermathen P, Ende G, Laxer KD, Knowlton RC, Matson GB, Weiner MW. Hippocampal N-acetylaspartate in neocortical epilepsy and mesial temporal lobe epilepsy. Ann Neurol 1997; 42: 194-9.